Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease.
Frommert LM, Arumahandi de Silva AN, Zernicke J, Scholz V, Braun T, Jeworowski LM, Schwarz T, Tober-Lau P, Ten Hagen A, Habermann E, Kurth F, Sander LE, Corman VM, Burmester GR, Biesen R, Albach FN, Klotsche J.
Frommert LM, et al. Among authors: braun t.
RMD Open. 2022 Dec;8(2):e002650. doi: 10.1136/rmdopen-2022-002650.
RMD Open. 2022.
PMID: 36597977
Free PMC article.